Article

Development of CAR-T Cell Therapy for B-ALL Using a Point-of-Care Approach

2019-09-16

Abstract excerpt

Recently approved by the FDA and European Medicines Agency, CAR-T cell therapy is a new treatment option for B-cell malignancies. Currently, CAR-T cells are manufactured in centralized facilities and face bottlenecks like complex scaling up, high costs and logistic operations. These difficulties are mainly related to the use of viral vectors and the requirement to expand CAR-T cells to reach the therapeutic dose....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a74c4846-f170-5c31-9f70-e53fb3c68e0f
DOI: 10.1101/770297

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of CAR-T Cell Therapy for B-ALL Using a Point-of-Care ApproachDOI 10.1101/770297Read

The Past, Present, and Future of Non-Viral CAR T CellsSemantic proximity Read

Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?Semantic proximity Read

Engineering strategies to safely drive CAR T-cells into the futureSemantic proximity Read

Current Non-Viral-Based Strategies to Manufacture CAR-T CellsSemantic proximity Read

Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignancesSemantic proximity Read

CAR T Cell Therapy: A Versatile Living DrugSemantic proximity Read

Optimization of electroporation and other non‐viral gene delivery strategies for T cellsSemantic proximity Read

CAR T-cell Therapy: A New Era in Cancer ImmunotherapySemantic proximity Read

Application and Design of Switches Used in CARSemantic proximity Read

A new approach to gene therapy using <i>Sleeping Beauty</i> to genetically modify clinical‐grade T cells to target <scp>CD</scp>19Semantic proximity Read

CAR T cell engineering impacts antigen-independent activation and co-inhibitionSemantic proximity Read

Automated, scaled, transposon-based production of CAR T cellsSemantic proximity Read